Summary of this blog
- A HealthTech LinkedIn strategy is founder content written for one buyer and traced to enquiries. Applause from other founders is a by-product. The point is the head of digital at a hospital or the owner of a dental group who sends a message after reading.
- Founder content works when it is measured. The Edelman and LinkedIn 2024 business-to-business (B2B) thought leadership report found 75% of buyers researched a product they were not considering after reading a piece, and 73% trust thought leadership more than marketing materials as a basis for judging competence. Only 29% of producers can link leads to specific pieces.
- Six moves. Pick the one buyer and the three questions she asks. Post weekly observations from real work, without client names. Publish proof posts that link to evidence pages. Treat comments and direct messages as the conversion step. Build the handoff to the site, one page per topic. Measure by enquiries and demo requests rather than impressions.
- Health narrows what a founder may say. Patient details stay out of every post, health claims need evidence, and clinic founders in the UK write inside the General Medical Council and Advertising Standards Authority rules.
- Start with one buyer and one post a week. The first enquiry that cites a post is the signal the plan is working, and it arrives long before the follower count does.
A HealthTech LinkedIn strategy is judged by the enquiries it produces, and most founder content produces applause instead. A post about the state of the sector earns three hundred likes from other founders and nothing from the buyer. The buyer is a head of digital at a hospital or the owner of a four-site dental group, and she reads LinkedIn differently. She is looking for someone who understands her setting, says something she can use on Monday, and can be checked. Founder content written for her earns fewer likes and brings in enquiries, and this guide is about writing it.
The case for founder content is strong and well measured. The Edelman and LinkedIn 2024 B2B Thought Leadership Impact Report, from nearly 3,500 management-level professionals in seven countries, found 75% of buyers say a piece of thought leadership led them to research a product they were not considering. And 73% consider thought leadership a more trustworthy basis for judging a supplier’s competence than marketing materials. The same report found only 29% of producers can link leads or wins to specific pieces. A HealthTech LinkedIn strategy built for inbound closes that gap, because every post is written to be traced to an enquiry.
This guide sets out six HealthTech LinkedIn strategy moves for the founder, or the head of marketing who writes with the founder, at a HealthTech company, a health software business or a clinic group. Our pillar on working with a HealthTech marketing agency covers where founder content sits in the wider programme, and our guide to HealthTech demand generation covers the pipeline the content feeds.
A HealthTech LinkedIn strategy is one observation a week from real work, written for one buyer, with a page behind it she can check. Applause is the by-product; the enquiry is the point.
The last-ten-posts test
Open the founder’s last ten posts and mark each one with two answers: who was it written for, and what could a buyer do with it on Monday? If the answers are “other founders” and “nothing” more than five times, the content is earning applause. A HealthTech LinkedIn strategy starts from that count, because it says how far the writing is from the buyer.
1. Pick the one buyer and her three questions
The first move is to choose who the posts are for, and to choose one person. A post written for founders, investors, clinicians and procurement at once is written for nobody. A HealthTech LinkedIn strategy picks the buyer the company most needs to hear from, such as the head of digital at a 300-bed hospital or the owner of a four-site dental group. Then it writes down the three questions she asks before she will talk to a vendor. Every post answers one of the three.
The three questions
In health the three are usually the same shape. Will this work in my setting, with my record system and my staff? What will it cost me in time and disruption, and who has done it before? Can I trust the people behind it when a regulator or my board asks? Write them in the buyer’s words, from the last ten sales calls. A HealthTech LinkedIn strategy that answers these three questions in rotation is read by the person who asks them.
The test
Read the buyer sentence to the sales team and ask them to name three customers who match it and three prospects who do not. If they can, the choice is real. 6sense’s Buyer Experience Report found 61% of buyers have a favourite vendor before first contact, and 8 in 10 choose that favourite. The founder’s posts are how a company becomes the favourite of one buyer before she gets in touch, and a HealthTech LinkedIn strategy aimed at everyone becomes nobody’s favourite.
2. Post weekly observations from real work
The second move is the cadence and the raw material. One post a week, every week, for a year, each one an observation from real work: what a hospital’s integration review asked for, what changed when a clinic group moved its booking online, what a pilot taught the team. No client names, no patient details, no figures the customer has not approved. A HealthTech LinkedIn strategy runs on observations because they are the one thing a competitor cannot copy and a buyer cannot find elsewhere.
The weekly observation
Three parts. The situation, in the buyer’s setting, described so she recognises it. The thing the team noticed that she would not expect. What she can do with it on Monday. Two hundred words, no links in the first line, written on Friday from the week’s calls, is the unit of a HealthTech LinkedIn strategy. At Healthora, we have seen that founders who keep this cadence for a quarter tend to be recognised by name on first calls, and the calls start further along than they used to.
What a health founder may say
Health narrows the material. In the US, patient information sits under the Health Insurance Portability and Accountability Act (HIPAA), and the Department of Health and Human Services (HHS) guidance on HIPAA and marketing sets out when a patient’s authorisation is needed before her information appears in a marketing communication. A patient story needs written permission or stays out. Health claims sit under the Federal Trade Commission’s Health Products Compliance Guidance, which requires “competent and reliable scientific evidence” behind them.
In the UK, a clinic founder writes inside the General Medical Council’s key points on cosmetic interventions, which cover how doctors may market them, and the Advertising Standards Authority’s guidance on before-and-after photos. A HealthTech LinkedIn strategy that stays inside these lines keeps every observation usable, and a founder who learns them once writes faster, because the question of what may be said is already answered.
3. Publish proof posts that link to evidence pages
The third move is the proof post, one in every four. An observation says what the team noticed; a proof post says what the team can show. The outcome from a pilot with its baseline, the integration listing on the record system vendor’s marketplace, the security certification, the published method. Each proof post links to a page on the company’s site where the evidence lives, with a named author and the sources. A HealthTech LinkedIn strategy without proof posts is a year of opinions.
The evidence page behind the post
One page per claim, written to survive a regulator’s reading and a competitor’s. Who the organisation type was, what the baseline was, what changed, how it was measured, who signed it off. The post carries the one line; the page carries the rest. Our guide to HealthTech investor marketing covers the same evidence pages, because an investor reads them the way a hospital buyer does. A HealthTech LinkedIn strategy and an investor programme share the founder’s voice and the proof behind it.
Why the proof post converts
Edelman and LinkedIn found 86% of buyers would be moderately or very likely to invite a consistent producer of thought leadership into a request for proposal (RFP), and only 48% rate the quality of what they read as good. The proof post is the one most founders never write, because it needs a page to exist first. A HealthTech LinkedIn strategy that publishes one a month is competing with very few others for the buyer who checks.
A specialist’s view on your founder content
Want a HealthTech LinkedIn strategy built from your last ten posts?
Book a free consultation with Healthora. We’ll read the founder’s last ten posts with you, tell you candidly who they were written for, and share a weekly plan you can start next Friday, whether you decide to work with us or not.
Book a Free Consultation4. Treat comments and messages as the conversion step
The fourth move is where inbound is won or lost. A buyer rarely sends a demo request from a post. She comments, or she reacts three weeks running, or she sends a direct message (DM) with a question. That is the enquiry, and most founders answer it as a courtesy and move on. A HealthTech LinkedIn strategy treats every comment and message from a buyer as a sales conversation that started on her terms, and answers it with the next useful thing rather than a pitch.
The reply that moves it
Answer the question fully in the comment, in public, where the other buyers reading can see it. Then, if the question was specific to her setting, offer one thing by message: the evidence page, a fifteen-minute call with the person who ran the pilot, a one-page note. TrustRadius’s 2024 B2B Buying Disconnect found 44% of buyers stop engaging when asked for contact details too early. The ask comes after the help, and a HealthTech LinkedIn strategy that gets the order wrong loses the buyer at the first message.
The founder’s half hour
Thirty minutes a day, in the morning, on comments and messages from people who match the buyer sentence. Everyone else gets a like, and the HealthTech LinkedIn strategy half hour is the one appointment the founder keeps. At Healthora, we have seen that founders who keep this half hour tend to find that first calls are booked from a message thread rather than a form, and that those calls are shorter, because the buyer has already read the proof. Our guide to B2B HealthTech marketing covers the handoff from the founder’s thread to the sales team.
5. Build the handoff to the site, one page per topic
The fifth move is the site, because a post that earns interest with nowhere to send it earns applause. For every topic the founder posts about, the site carries one page that goes further: the full observation, the evidence, the method, the next step. The post is the headline; the page is the article. A HealthTech LinkedIn strategy that posts on twelve topics a year has twelve pages, each linked from the posts and the profile, each with its own demo path.
The page per topic
A page the buyer can read without a form, with a named author, the sources and the proof. A CTA that offers help before it offers a demo. The same page is what search and AI answers cite when the buyer asks the question the post raised, so it carries the same words the post used. Gartner reports 75% of B2B buyers prefer a rep-free experience, and the page is the rep-free version of the founder. A HealthTech LinkedIn strategy and an SEO programme meet on this page.
The profile as the front door
The founder’s profile is the page most buyers open first, and on most founders it reads like a job history. Rewrite it for the buyer: who the founder helps, the three questions, and a featured section with the three best proof posts and the three pages behind them. The company page carries the same. Nothing in a HealthTech LinkedIn strategy sends a buyer to a homepage that cannot say who it is for; the page per topic says it in the first line.
6. Measure by enquiries and demo requests
The sixth move is the number. Impressions and followers are what the platform reports, and they are what most founders report to their board. Neither is an outcome. A HealthTech LinkedIn strategy is measured by enquiries from people who match the buyer sentence, demo requests that cite a post, and pipeline the sales team can trace to a thread. Edelman and LinkedIn found 42% of producers measure thought leadership by traffic and 19% do not measure it at all, which is why most cannot say whether it works.
The one-page scorecard
Five lines, updated monthly. Posts published against the plan. Comments and messages from people matching the buyer. Enquiries and demo requests that name a post or a topic. First calls booked from a thread. Pipeline traced to founder content. The first three move within a quarter and the last two within two. A HealthTech LinkedIn strategy with this scorecard can be defended to a board; one measured in impressions cannot.
The question to ask every new enquiry
Add one line to the enquiry form and one question to the first call: where did you first come across us? Write the answer down every time. Within a quarter the answers say which posts and which topics produced buyers, and the next quarter’s HealthTech LinkedIn strategy is written from the list. At Healthora, we have seen that the answer is “a post” far more often than the attribution software says, because the buyer read it weeks before she searched.
HealthTech LinkedIn strategy in practice: the first quarter
A HealthTech LinkedIn strategy is set up in a month and judged over a quarter. Month one runs the last-ten-posts test, writes the buyer sentence and her three questions, rewrites the founder’s profile, and publishes the first four observations. Then month two adds the first proof post and the evidence page behind it, starts the founder’s daily half hour on comments and messages, and adds the “where did you first come across us” line to the form. Month three publishes the second proof post, builds the next two topic pages, and fills in the first scorecard.
The change shows first in the comments. People who match the buyer sentence start asking questions in public, and the founder’s replies become the most-read lines of the week. Then the first message arrives that cites a post, and the first call booked from a thread is shorter than any booked from a form. A quarter in, the scorecard shows which topics produced enquiries. The HealthTech LinkedIn strategy for the next quarter is written from that list, and the follower count is the last number anyone looks at.
The recap below lists the six moves in the order to make them.
- Pick the one buyer and her three questions. A HealthTech LinkedIn strategy starts with one person, a head of digital or a practice owner, and the three questions she asks before she will talk to a vendor.
- Post weekly observations from real work. One a week, in three parts, with no client names, no patient details and no claim the evidence cannot carry.
- Publish proof posts that link to evidence pages. One in four HealthTech LinkedIn strategy posts shows what the team can prove, and links to the page where the proof lives under a named author.
- Treat comments and messages as the conversion step. Answer in public, help first, offer one thing by message, and keep the founder’s daily half hour. The HealthTech LinkedIn strategy conversion happens in the thread.
- Build the handoff to the site, one page per topic. Twelve topics, twelve pages, each read without a form, each cited by search and AI answers.
- Measure by enquiries and demo requests. The one-page scorecard and the “where did you first come across us” line. A HealthTech LinkedIn strategy is defended to the board in enquiries, never in impressions.
The six HealthTech LinkedIn strategy moves can be run by the founder alone, by a specialist agency that writes with the founder, or by the two together. Our services and case studies show what founder content and the pages behind it look like in engagements we have run, and the pillar above covers how the founder’s voice fits with the rest of the programme.
A specialist in health understands that the buyer reads a founder’s posts to decide whether to trust the company before she will talk to it, that the rules on what may be said are stricter in health than anywhere else, and that applause is the easiest thing on the platform to earn. Pick the buyer, post the observation, prove it, answer the thread, build the page, and count the enquiries. Then the founder’s voice is a source of pipeline rather than a source of likes.
Ready for founder content that produces enquiries?
HEALTHORA SPECIALISES IN HEALTH
Book a free consultation with Healthora. We’ll identify the one buyer your founder should be writing for, show you the six moves in order, and share a posting plan you can start next week, whether you decide to work with us or not.
Book a Free ConsultationFrequently asked questions
What is a HealthTech LinkedIn strategy?
Founder content written for one buyer and measured by enquiries. One observation a week from real work, one proof post in four linked to an evidence page, the founder’s daily half hour on comments and messages, a page on the site for every topic, and a scorecard that counts enquiries and demo requests rather than impressions. Applause from other founders is a by-product.
How often should a HealthTech founder post on LinkedIn?
Once a week, every week, for a year, is enough when every post is written for the buyer. Three observations and one proof post a month is a HealthTech LinkedIn strategy that beats daily posts written for the feed. The cadence matters more than the volume, because the buyer who reads for a quarter before she gets in touch needs to see the founder there every week she looks.
Can a founder share patient or client stories on LinkedIn?
Only with permission. In the US the HHS guidance on HIPAA and marketing sets out when a patient’s authorisation is needed before her information appears in a marketing communication, and a customer’s name or figures need written approval. A HealthTech LinkedIn strategy writes the observation without the name: the organisation type, the situation and what changed.
Should founder content link to the company website?
Yes, from the comments or the end of the post, to one page per topic that goes further than the post and can be read without a form. The page carries the evidence, a named author and the sources, and it is the page search and AI answers cite when a buyer asks the question the post raised. A post without a page earns applause with nowhere to send it.
How do you measure founder content on LinkedIn?
By enquiries and demo requests from people who match the buyer sentence, first calls booked from a message thread, and pipeline the sales team can trace to a post. Add “where did you first come across us” to the form and the first call. Edelman and LinkedIn found only 29% of producers can link leads to specific pieces, and a HealthTech LinkedIn strategy scorecard is how a company joins them.
Does LinkedIn work for clinics and health brands as well as HealthTech companies?
Yes. A dental group owner or a longevity clinic founder reaches referring clinicians, corporate buyers and partners the same way, with observations from the practice and the proof the Advertising Standards Authority and General Medical Council rules permit. The buyer changes and the six moves stay the same.
What does Healthora charge for a HealthTech LinkedIn strategy?
Fees depend on scope, from a one-off review built from the founder’s last ten posts to a quarterly engagement covering the plan, the proof posts, the topic pages and the scorecard, and are agreed for the engagement rather than billed by the hour. The consultation is free and includes the last-ten-posts test.
Keep reading
More on turning founder attention into pipeline: